CTAD 2025

Neurodegeneration
-
San Diego
,
United States of America

We will be present at this event with meeting spaces available. 

Poster Sessions:

Wednesday, December 3, 7:15am - 5:30pm: Group 7: "CLINICAL TRIALS: BIOMARKERS INCLUDING PLASMA"

  • P236 ADxPLORER: filling the gap for early-stage fluid biomarker research on the fully automated LUMIPULSE® G1200 Platform 
    • Presenter: Nathan Blancke, ADx NeuroSciences
  • P234 Performance testing of the novel DDC Xplorer Lumipulse G1200 immunoassay for measuring DOPA Decarboxylase in Cerebrospinal Fluid (CSF) 
    • Presenter: Erik Stoops, ADx NeuroSciences

 

Flash Presentation:

Wednesday, December 3, 3:50pm - 4:20pm: Session 4 - Multiomics and Precision Diagnostics

  • Fujirebio/ADx NeuroSciences — ADxPLORER qualified assays for early biomarker access "The chicken or the egg - why is ADxPLORER filling a crucial gap?"

 

Late Breaking Communications (LUMIPULSE):

Thursday, December 4, 8:45am

  • LB24 pTau 217 performance to separate Alzheimer's disease biological stage is not increased by adding demographic or clinical information
    • Contributor Mention: Manu Vandijck, Fujirebio Europe N.V. - Gent (Belgium)

Please contact us to schedule a meeting or for additional information.

Request a meeting at this event

Please fill in the form below to request a meeting with one of our team members.

CAPTCHA

The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.